The Emergence and Impact of GLP-1 Receptor Agonists on Obesity Management Drugs known as GLP-1 Receptor Agonists (GLP-1RAs), such as Ozempic, Mounjaro, and Wegovy, have surged to prominence in the pharmaceutical industry, heralded for their capabilities in facilitating weight loss. Initially developed for the treatment of Type 2 diabetes mellitus (T2DM), these medications exploit normal...
Premium Membership Required
You must be a Premium member to access this content.
Already a member? Log in here
